| Risk identifying Cohort | Validation Cohort |  | ||
---|---|---|---|---|---|
N= | 4916 | N= | 1224 | p | |
Age, median (IQR) y | 35.46 | (27.50) | 38.00 | (27.81) | 0.324 |
Sex | Â | Â | Â | Â | Â |
 Female | 1503 | 30.57% | 367 | 29.98% | 0.703 |
 Male | 3413 | 69.43% | 857 | 70.02% |  |
Trauma severity | Â | Â | Â | Â | Â |
Traffic accident | 1882 | 38.28% | 466 | 38.07% | 0.895 |
Spleen laceration severity | Â | Â | Â | Â | 0.455 |
 Hematoma of spleen without laceration | 669 | 13.61% | 180 | 14.71% |  |
 Capsular tears without parenchymal injury | 289 | 5.88% | 82 | 6.70% |  |
Laceration into parenchyma | 429 | 8.73% | 99 | 8.09% | Â |
Massive parenchymal disruption | 1062 | 21.60% | 275 | 22.47% | Â |
 Unspecified splenic injury | 2467 | 50.18% | 588 | 48.04% |  |
ISS ≥ 16 | 512 | 10.41% | 151 | 12.34% | 0.057 |
Accompanying damage | Â | Â | Â | Â | Â |
 Intracranial hemorrhage | 238 | 4.84% | 55 | 4.49% | 0.653 |
 Hemothorax | 787 | 16.01% | 203 | 16.58% | 0.633 |
 Blunt hepatic injury | 600 | 12.21% | 153 | 12.50% | 0.770 |
 Blunt renal injury | 600 | 12.21% | 153 | 12.50% | 0.770 |
 Pelvic fracture | 212 | 4.31% | 46 | 3.76% | 4.260 |
 Femoral fracture | 182 | 3.70% | 44 | 3.59% | 0.932 |
 Length of hospitalization, median (IQR) | 8 | (8) | 8 | (7) | 0.355 |
Major coexisting disease | Â | Â | Â | Â | Â |
 Myocardial infarction | 18 | 0.37% | 7 | 0.57% | 0.316 |
 Congestive heart failure | 84 | 1.71% | 13 | 1.06% | 0.123 |
 Vascular disease | 23 | 0.47% | 7 | 0.57% | 0.647 |
 Cerebrovascular disease | 137 | 2.79% | 35 | 2.86% | 0.923 |
 Dementia | 7 | 0.14% | 4 | 0.33% | 0.246 |
 Chronic pulmonary disease | 166 | 3.38% | 43 | 3.51% | 0.792 |
 Rheumatic disease | 22 | 0.45% | 5 | 0.41% | 1.000 |
 Peptic ulcer disease | 330 | 6.71% | 81 | 6.62% | 0.949 |
 Severe liver disease | 58 | 1.18% | 16 | 1.31% | 0.663 |
 Diabetes mellitus | 311 | 6.33% | 73 | 5.96% | 0.692 |
 Hemiplegia | 38 | 0.77% | 6 | 0.49% | 0.348 |
 On dialysis | 19 | 0.39% | 2 | 0.16% | 0.408 |
 Malignancy | 138 | 2.81% | 36 | 2.94% | 0.773 |
 HTN | 434 | 8.83% | 112 | 9.15% | 0.736 |
 Hyperlipidemia | 165 | 3.36% | 27 | 2.21% | 0.043* |
 Gout | 126 | 2.56% | 31 | 2.53% | 1.000 |
 Obesity | 7 | 0.14% | 2 | 0.16% | 0.697 |
Rebleeding requiring interventions | 61 | 1.24% | 19 | 1.55% | 0.398 |
 Splenectomy | 54 | 88.52% | 17 | 89.47% | 1.000 |
 Transcatheter arterial embolization | 7 | 11.48% | 2 | 10.53% | 1.000 |
 Length of hospitalization, median (IQR) | 9 | (8) | 10 | (6) | 0.919 |
 In-hospital mortality | 0 | 0.00% | 0 | 0.00% |  |
Duration from discharge | 7 | (19) | 5 | (12) | 0.667 |
Duration from the first admission | 18 | (24) | 12 | (16) | 0.553 |